Literature DB >> 27526295

Lymphocytic Esophagitis in Nonachalasia Primary Esophageal Motility Disorders: Improved Criteria, Prevalence, Strength of Association, and Natural History.

Juan Putra1, Kristen E Muller, Zilla H Hussain, Siddhartha Parker, Scott Gabbard, Elizabeth B Brickley, Brian E Lacy, Richard Rothstein, Mikhail Lisovsky.   

Abstract

Lymphocytic esophagitis (LE) is a histologic pattern with no established clinical correlates in the majority of patients. The goal of this study was to evaluate the association between nonachalasia primary esophageal motility disorders (PEMD) and LE. Sixty-nine patients with PEMD and esophageal biopsies, including 22 with nutcracker esophagus, 33 with ineffective motility, and 14 with diffuse spasm, constituted the study group. The control group consisted of 70 patients with severe dysmotility-negative gastroesophageal reflux disease requiring referral for Nissen fundoplication. To improve the criteria for LE, a lymphocyte reference range at different esophageal levels was first established in 17 healthy volunteers. The cutoffs for normal intraepithelial lymphocytes, defined as lymphocyte levels not exceeding mean level±2 SDs, were set at 62, 46, and 41 lymphocytes per high-power field at 0 to 2, 5, and 10 cm above the gastroesophageal junction, respectively. Predominantly focal peripapillary LE was observed in approximately 40% of patients with nutcracker esophagus or diffuse spasm and in 20% of patients with ineffective motility, in comparison with 4% of patients with dysmotility-negative gastroesophageal reflux disease (P<0.035 vs. any subtype of PEMD). Overall, LE was strongly associated with PEMD in multivariate analysis (adjusted odds ratio, 7.93; 95% confidence interval, 2.26-27.9; P=0.001). LE had a chronic course in 56% of the patients with follow-up biopsies. In conclusion, LE has a strong association with PEMD, suggesting the utility of LE in raising the possibility of PEMD.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27526295      PMCID: PMC5613759          DOI: 10.1097/PAS.0000000000000712

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  24 in total

1.  Safety and tolerability of transoral Bravo capsule placement after transnasal manometry using a validated conversion factor.

Authors:  Brian E Lacy; Tracia O'Shana; Mary Hynes; Maurice L Kelley; Julia E Weiss; Lisa Paquette; Richard I Rothstein
Journal:  Am J Gastroenterol       Date:  2006-11-13       Impact factor: 10.864

2.  Post-ablation lymphocytic esophagitis in Barrett esophagus with high grade dysplasia or intramucosal carcinoma.

Authors:  Juliana Kissiedu; Prashanthi N Thota; Tushar Gohel; Rocio Lopez; Ilyssa O Gordon
Journal:  Mod Pathol       Date:  2016-03-11       Impact factor: 7.842

3.  Histological consequences of gastroesophageal reflux in man.

Authors:  F Ismail-Beigi; P F Horton; C E Pope
Journal:  Gastroenterology       Date:  1970-02       Impact factor: 22.682

4.  Squamous mucosal alterations in esophagectomy specimens from patients with end-stage achalasia.

Authors:  M B Lehman; S B Clark; A H Ormsby; T W Rice; J E Richter; J R Goldblum
Journal:  Am J Surg Pathol       Date:  2001-11       Impact factor: 6.394

5.  Evaluation of T-lymphocytes in esophageal mucosal biopsies.

Authors:  H H Wang; M M Mangano; D A Antonioli
Journal:  Mod Pathol       Date:  1994-01       Impact factor: 7.842

6.  Lymphocytes and Langerhans cells in the human oesophageal epithelium.

Authors:  K Geboes; C De Wolf-Peeters; P Rutgeerts; J Janssens; G Vantrappen; V Desmet
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1983

7.  Lymphocytic esophagitis: a possible manifestation of pediatric upper gastrointestinal Crohn's disease.

Authors:  Dawn R Ebach; Andrew D Vanderheyden; Jason M Ellison; Chris S Jensen
Journal:  Inflamm Bowel Dis       Date:  2011-01       Impact factor: 5.325

8.  Validation of the GerdQ questionnaire for the diagnosis of gastro-oesophageal reflux disease.

Authors:  C Jonasson; B Wernersson; D A L Hoff; J G Hatlebakk
Journal:  Aliment Pharmacol Ther       Date:  2013-01-07       Impact factor: 8.171

9.  Lymphocytic esophagitis: a chronic or recurring pattern of esophagitis resembling allergic contact dermatitis.

Authors:  Julianne K Purdy; Henry D Appelman; Christopher P Golembeski; Barbara J McKenna
Journal:  Am J Clin Pathol       Date:  2008-10       Impact factor: 2.493

10.  Endoscopic, bioptic, and manometric findings in eosinophilic esophagitis before and after steroid therapy: a case series.

Authors:  A J Lucendo; J M Pascual-Turrión; M Navarro; C Comas; P Castillo; A Letrán; M T Caballero; J Larrauri
Journal:  Endoscopy       Date:  2007-09       Impact factor: 10.093

View more
  4 in total

1.  A Positive Correlation Between Gastric and Esophageal Dysmotility Suggests Common Causality.

Authors:  Thomas A Zikos; John O Clarke; George Triadafilopoulos; Kirsten A Regalia; Irene S Sonu; Nielsen Q Fernandez-Becker; Monica C Nandwani; Linda A Nguyen
Journal:  Dig Dis Sci       Date:  2018-06-26       Impact factor: 3.199

Review 2.  Esophagitis unrelated to reflux disease: current status and emerging diagnostic challenges.

Authors:  Melanie E Johncilla; Amitabh Srivastava
Journal:  Virchows Arch       Date:  2017-10-15       Impact factor: 4.064

Review 3.  Chronic fibrosing esophagitis with diffuse esophageal intramural pseudo-diverticulosis.

Authors:  Florian Hentschel
Journal:  JGH Open       Date:  2022-05-11

Review 4.  Lymphocytic esophagitis: Still an enigma a decade later.

Authors:  Carol Rouphael; Ilyssa O Gordon; Prashanthi N Thota
Journal:  World J Gastroenterol       Date:  2017-02-14       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.